Skip to main content
ALNY logo
ALNY
(NASDAQ)
Alnylam Pharmaceuticals, Inc.
$318.85-- (--)
Loading... - Market loading

Alnylam Pharmaceuticals (ALNY) Stock Price & Financial Analysis

Alnylam Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$315.90 - $325.49
52-Week High$495.55
52-Week Low$205.87
Open$323.03
Volume872.43K
Average Volume (3M)872.43K
Market Cap42.94B
Shares Outstanding134.68M
P/E Ratio (TTM)141.12
Price to Sales (P/S)11.92
Price to Book (P/B)56.10
EV/EBITDA69.16
Revenue (TTM)3.71B
Net Income (TTM)313.75M
Free Cash Flow (TTM)465.38M
EPS (TTM)$2.30
Profit Margin8.45%
Operating Margin13.51%
Return on Equity (ROE)39.76%
Debt to Equity1.33
50-Day MA$329.60
200-Day MA$393.19
52-Week Change28.53%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Alnylam Pharmaceuticals

What is the current stock price for ALNY?

As of the latest trading session, ALNY stock trades at $318.85. The 52-week range is $205.87–$495.55, with a day range of $315.89–$325.49.

What is the P/E ratio for ALNY?

Alnylam Pharmaceuticals's trailing P/E ratio is 141.1, meaning investors pay $141.1 for every $1 of annual earnings. Alnylam Pharmaceuticals operates in the Healthcare sector.

Does ALNY pay dividends?

Alnylam Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ALNY?

Based on 29 analysts, the consensus for ALNY is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ALNY?

Alnylam Pharmaceuticals's market capitalization is $42.94B, classifying it as a large-cap company. Alnylam Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.